title: The apolipoprotein b/apolipoprotein AI ratio in the metabolic syndrome-should we start using it?
authors.affiliation: Department of Internal Medicine, Mayo Clinic and Foundation, Rochester MN, USA. jusier@ki.se
authors.forename: Justo
authors.initials: J
authors.lastname: Sierra-Johnson
authors.forename: Abel
authors.initials: A
authors.lastname: Romero-Corral
authors.forename: Virend K
authors.initials: VK
authors.lastname: Somers
authors.forename: Francisco
authors.initials: F
authors.lastname: Lopez-Jimenez
mesh_terms: D016632:Apolipoprotein A-I / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D024821:Metabolic Syndrome / Q000097:blood*; D011237:Predictive Value of Tests; D012307:Risk Factors
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D015415:Biomarkers